McDonald Andrew's most recent trade in Cushman & Wakefield plc was a trade of 161,765 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 26, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 161,765 | 161,765 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 29,123 | 324,982 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.01 per share. | 26 Feb 2025 | 14,789 | 310,193 (0%) | 0% | 12.0 | 177,616 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2025 | 34,878 | 303,506 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2025 | 34,878 | 34,878 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2025 | 20,787 | 306,415 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2025 | 20,787 | 0 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.64 per share. | 23 Feb 2025 | 17,878 | 285,628 (0%) | 0% | 11.6 | 208,100 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.74 per share. | 23 Feb 2025 | 10,556 | 295,859 (0%) | 0% | 11.7 | 123,927 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 20,666 | 0 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 20,666 | 278,875 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.61 per share. | 14 Aug 2024 | 10,247 | 268,628 (0%) | 0% | 12.6 | 129,215 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 10,697 | 263,513 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 10,697 | 21,394 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.08 per share. | 01 Jul 2024 | 5,304 | 258,209 (0%) | 0% | 10.1 | 53,464 | Ordinary Shares |
Cushman & Wakefield plc | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 2,963 | 0 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 2,963 | 254,286 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.83 per share. | 27 Feb 2024 | 1,470 | 252,816 (0%) | 0% | 9.8 | 14,450 | Ordinary Shares |
Cushman & Wakefield plc | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 46,208 | 267,308 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 34,878 | 210,758 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 34,878 | 69,756 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 20,787 | 20,787 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 20,787 | 219,335 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 17,759 | 229,905 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | McDonald Andrew | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 17,759 | 0 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.82 per share. | 23 Feb 2024 | 15,985 | 251,323 (0%) | 0% | 9.8 | 156,973 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.82 per share. | 23 Feb 2024 | 12,210 | 198,548 (0%) | 0% | 9.8 | 119,902 | Ordinary Shares |
Cushman & Wakefield plc | McDonald Andrew | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.82 per share. | 23 Feb 2024 | 8,805 | 221,100 (0%) | 0% | 9.8 | 86,465 | Ordinary Shares |
Cushman & Wakefield plc | McDonald Andrew | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.82 per share. | 23 Feb 2024 | 7,189 | 212,146 (0%) | 0% | 9.8 | 70,596 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2023 | 20,667 | 186,127 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2023 | 20,667 | 20,666 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.76 per share. | 14 Aug 2023 | 10,247 | 175,880 (0%) | 0% | 9.8 | 100,011 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 32,091 | 32,091 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 3,152 | 0 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 3,152 | 167,023 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.55 per share. | 07 Mar 2023 | 1,563 | 165,460 (0%) | 0% | 12.6 | 19,616 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 25,296 | 172,619 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.88 per share. | 03 Mar 2023 | 8,748 | 163,871 (0%) | 0% | 12.9 | 112,674 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 2,964 | 2,963 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 2,964 | 148,348 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.89 per share. | 27 Feb 2023 | 1,025 | 147,323 (0%) | 0% | 12.9 | 13,212 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 20,787 | 141,142 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 20,787 | 41,574 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 17,759 | 17,759 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 17,759 | 151,526 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 24 Feb 2023 | 7,375 | 133,767 (0%) | 0% | 13.0 | 95,728 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 24 Feb 2023 | 6,142 | 145,384 (0%) | 0% | 13.0 | 79,723 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 104,634 | 104,634 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2022 | 20,667 | 41,333 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2022 | 20,667 | 130,602 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.50 per share. | 14 Aug 2022 | 10,247 | 120,355 (0%) | 0% | 16.5 | 169,076 | Ordinary Shares |
Vincerx Pharma Inc | Andrew McDonald | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
Cushman & Wakefield plc | Andrew McDonald | President | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 29 Mar 2022 | 2,061 | 109,935 (0%) | 0% | 21 | 43,281 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 3,151 | 113,086 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 3,151 | 3,152 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.89 per share. | 07 Mar 2022 | 1,090 | 111,996 (0%) | 0% | 18.9 | 20,590 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Sale of securities on an exchange or to another person at price $ 21.63 per share. | 02 Mar 2022 | 13,478 | 109,935 (0%) | 0% | 21.6 | 291,529 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 17,759 | 127,694 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 17,759 | 35,518 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.12 per share. | 25 Feb 2022 | 6,220 | 121,474 (0%) | 0% | 23.1 | 143,806 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 2,964 | 124,438 (0%) | 0% | 0 | Ordinary Shares | |
Cushman & Wakefield plc | Andrew McDonald | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 2,964 | 5,927 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.12 per share. | 25 Feb 2022 | 1,025 | 123,413 (0%) | 0% | 23.1 | 23,698 | Ordinary Shares |
Cushman & Wakefield plc | Andrew McDonald | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 62,361 | 62,361 | - | - | Restricted Stock Units | |
Cushman & Wakefield plc | Andrew McDonald | President | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 16 Feb 2022 | 10,000 | 109,935 (0%) | 0% | 23 | 230,000 | Ordinary Shares |
Vincerx Pharma Inc | Andrew McDonald | Director | Purchase of securities on an exchange or from another person at price $ 12.38 per share. | 29 Jun 2021 | 20,000 | 20,000 | - | 12.4 | 247,600 | Common Stock |
Vincerx Pharma Inc | Andrew McDonald | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Vincerx Pharma Inc | Andrew McDonald | Director | Other type of transaction at price $ 0.00 per share. | 28 Jan 2021 | 1,616,942 | 0 | - | 0 | Common Stock | |
Vincerx Pharma Inc | Andrew McDonald | Director | Other type of transaction at price $ 0.00 per share. | 28 Jan 2021 | 808,471 | 808,471 | - | 0 | Common Stock | |
Vincerx Pharma Inc | Andrew McDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2020 | 6,667 | 6,667 | - | - | Stock Option (right to buy) |